go back

Rhode Island rates for HCPCS Q2056

Ciltacabtagene autoleucel, up to 100 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $588,844 · 10th–90th $588,844–$1,148,1540%50%90th$588,844Professionalmedian $588,844 · 10th–90th $588,844–$616,5950%50%90th$588,844$100.0K$200.0K$500.0K$1.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample — interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$1,148,153.62 / $1,148,153.62 / $1,148,153.62
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$588,843.66 / $616,595.00 / $616,595.00
BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$588,843.66 / $588,843.66 / $616,595.00
BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$588,843.66 / $588,843.66 / $588,843.66
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$89,125.09 / $89,125.09 / $89,125.09